Canaan XI L.P.
SEC CIK 1712417 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | 10% | 473.4K | — | — | 1 | 2021-09-17 | 2021-09-17 |
Most active insiders at TYRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORE ROBERT J | Dir | — | $5.25M |
| 2 | Bensen Daniel | Chief Discovery Off | — | $4.81M |
| 3 | KAPLAN GILLA | Dir | — | $528.5K |
| 4 | Verjee Rehan | Dir | $20.0K | — |
| 5 | Rueb Yuliya | VP, Fin (PAO) | — | — |
| 6 | Warner Douglas J | Chief Medical Off | — | — |
| 7 | Ashar Bhavesh | COO | — | — |
| 8 | Harris Todd | Pres, CEO, Dir | — | — |
| 9 | Fuhrman Alan | CFO | — | — |
Canaan XI L.P. made no open-market trades at TYRA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-20 | 2021-09-17 | TYRA | Tyra Biosciences, Inc. | Canaan XI L.P. | 10% | C - Cnv Deriv | — | +4.41M | 473.4K | New | — |
Purchase Sale Sale after option exercise All abbreviations